Following encouraging trial findings , retatrutide, a novel peptide option for treating type 2 hyperglycemia , has secured regulatory approval from Great Britain's Drug and Products Agency (MHRA ). https://shopretatrutidepeptide.com/category/retatrutide-peptide/